Recruiting Schizophrenia Studies in Bellflower
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
This is a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants with Schizophrenia...
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
ML-007C-MA-211 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered ML-007C-MA in inpatient adult participants age...
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with schizophrenia with an inade...
About Schizophrenia Clinical Trials in Bellflower
Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.
There are currently 3 schizophrenia clinical trials recruiting participants in Bellflower, CA. These studies are seeking a combined 1,102 participants. Research is being sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., MapLight Therapeutics, Karuna Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Schizophrenia Clinical Trials in Bellflower — FAQ
Are there schizophrenia clinical trials in Bellflower?
Yes, there are 3 schizophrenia clinical trials currently recruiting in Bellflower, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bellflower?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bellflower research site will contact you about next steps.
Are clinical trials in Bellflower free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bellflower studies also compensate for your time and travel.
What schizophrenia treatments are being tested?
The 3 active trials in Bellflower are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.
Data updated March 2, 2026 from ClinicalTrials.gov